HLA DQA1∗05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children with Crohn's Disease

Jeremy Adler, Joseph A. Galanko, Rana Ammoury, Keith J. Benkov, Athos Bousvaros, Brendan Boyle, José M. Cabrera, Kelly Y. Chun, Jill Dorsey, Dawn R. Ebach, Ann M. Firestine, Ajay S. Gulati, Hans H. Herfarth, Traci W. Jester, Jess L. Kaplan, Ian Leibowitz, Tiffany M. Linville, Peter A. Margolis, Phillip Minar, Zarela Molle-RiosJonathan Moses, Kelly Olano, Dinesh S. Pashankar, Lisa Pitch, Shehzad A. Saeed, Charles M. Samson, Kelly Sandberg, Steven J. Steiner, Jennifer A. Strople, Jillian S. Sullivan, Prateek D. Wali, Michael D. Kappelman

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1076-1086
Number of pages11
JournalAmerican Journal of Gastroenterology
Volume120
Issue number5
DOIs
StatePublished - May 1 2025
Externally publishedYes

ASJC Scopus Subject Areas

  • Hepatology
  • Gastroenterology

Keywords

  • drug persistence
  • genotype
  • loss of response
  • pediatric

Cite this